Showing results (971-980 of 9,922) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|April 20, 2010
The care of critically ill children after hematopoietic SCT: a North American surveyJ McArthur, G Pettersen, P Jouvet, et al.
Bone Marrow Transplantation|April 20, 2010
Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trialsI Choi, R Tanosaki, N Uike, et al.
Bone Marrow Transplantation|April 20, 2010
A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignanciesA Takami, J L Espinoza, M Onizuka, et al.
Bone Marrow Transplantation|April 1, 1990
Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipientsL R Gottschalk, R A Bray, H Kaizer, et al.
Bone Marrow Transplantation|October 10, 2006
Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioningN S Majhail, K Parks, T E Defor, et al.
Bone Marrow Transplantation|October 10, 2006
Reduced-intensity unrelated cord blood transplantation for treatment of metastatic renal cell carcinoma: first evidence of cord-blood-versus-solid-tumor effectA Takami, H Takamatsu, H Yamazaki, et al.
Bone Marrow Transplantation|August 18, 2006
Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnoverR Yamazaki, M Kuwana, T Mori, et al.
Bone Marrow Transplantation|May 26, 2010
Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infectionK Kawa, A Sawada, M Sato, et al.
Bone Marrow Transplantation|May 19, 2010
Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosisR Onodera, S Teramukai, S Tanaka, et al.
Bone Marrow Transplantation|January 1, 1991
The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patientsJ Y Cahn, P Bordigoni, G Souillet, et al.
Pageof 993